Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bernardo Maria De Martino"'
Autor:
Maria Giuseppa Vitale, Anna Crispo, Dario Arundine, Riccardo Ronga, Carmela Barbato, Assunta Luongo, Francesco Habetswallner, Bernardo Maria De Martino, Angela Maione, Sandra Eisenwagen, Giovanna Vitale, Ferdinando Riccardi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Following the previously published results of the clinical randomized ZeOxaNMulti trial, we evaluated the potential of the tested product PMA-ZEO (Multizeo Med) in the prevention of chemotherapy-induced side effects (especially peripheral neuropathy)
Externí odkaz:
https://doaj.org/article/c4ca039d4289417693277ce6d9cd7067
Autor:
Maria Giuseppa Vitale, Carmela Barbato, Anna Crispo, Francesco Habetswallner, Bernardo Maria De Martino, Ferdinando Riccardi, Angela Maione, Sandra Eisenwagen, Giovanna Vitale, Giacomo Cartenì
Publikováno v:
Molecules, Vol 25, Iss 10, p 2297 (2020)
Chemotherapy-induced peripheral neuropathy (CIPN) is the most frequently reported adverse effect of oxaliplatin. In this study, we set out to evaluate the role of the panaceo-micro-activation (PMA) zeolite in the reduction of the incidence of CIPN an
Externí odkaz:
https://doaj.org/article/99ce61c348c446e1b1c00514644e71cf
Autor:
Assunta Trinchillo, Marcello Esposito, Francesco Habetswallner, Francesco Tuccillo, Bernardo Maria De Martino
Publikováno v:
Neurological Sciences. 44:447-450
Autor:
Giovanni Colacicco, Gaspare Guglielmi, Marida Massa, Carmela Simona Serio, Francesco Habetswallner, Bernardo Maria De Martino, Francesco Tuccillo, Eugenia Piscitelli
Publikováno v:
Eur J Hosp Pharm
Objectives Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired peripheral neuropathy of immunological origin with a clinical presentation and course that are extremely variable. The therapeutic approach generally includes corticos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c08325245d9a37756fd4e15609079c1
https://europepmc.org/articles/PMC8640425/
https://europepmc.org/articles/PMC8640425/
Autor:
Giacomo Cartenì, Bruno Chiurazzi, Ferdinando Riccardi, Francesco Habetswallner, Carmela Barbato, Bernardo Maria De Martino, Giorgio Bedogni, Felice Sirico, M. Biglietto, Maria Giuseppa Vitale
Publikováno v:
Journal of Clinical Oncology. 34:10117-10117
10117Background: Peripheral neuropathy is the most significant adverse reaction associated with the use of oxaliplatin. No treatment is presently available for the prevention of OXPNP. Alpha-lipoic...